An Act to promote transparency in prescription drug prices
By Ms. Forry, a petition (accompanied by bill, Senate, No. 627) of Linda Dorcena Forry and Daniel Cullinane for legislation to promote transparency in prescription drug prices. Health Care Financing.
Bill History
| Date | Branch | Action |
|---|---|---|
| 1/23/2017 | Senate | Referred to the committee on Health Care Financing |
| 1/23/2017 | House | House concurred |
| 6/12/2017 | Joint | Hearing scheduled for 07/11/2017 from 11:00 AM-01:00 PM in B-1 |
| 3/1/2018 | Senate | Reporting date extended to Wednesday April 25, 2018, pending concurrence |
| 3/1/2018 | House | House concurred |
| 4/24/2018 | House | Reporting date extended to Wednesday May 16, 2018, pending concurrence |
| 4/26/2018 | Senate | Senate concurred |
| 5/31/2018 | Senate | Accompanied a study order, see S2535 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.